DermTech, Inc. (NASDAQ:DMTK) Q4 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to DermTech's Fourth Quarter 2023 Financial Results Call. At this time, all participants are in a listen-only mode.
Dermtech Inc. (DMTK)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Hongkou Capital Xiaotong (Peter) Zhou | 402,526 | $704,421 | 0.89% | |
| 2. | Citadel Investment Group Ken Griffin | 316,793 | $554,388 | +2542% | 0% |
| 3. | Millennium Management Israel Englander | 157,406 | $275,460 | 0% | |
| 4. | 107,200 | $187,600 | +32% | 0% | |
| 5. | D E Shaw D. E. Shaw | 69,108 | $120,939 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.86 | 20,000 | Director | 72,382 | 2022-05-09 | Filing | |
| $6.86 | 20,000 | Director | 72,832 | 2022-05-09 | Filing | |
| $29.50 | 33,898 | Director | 86,863 | 2021-01-11 | Filing | |
| $29.50 | 200,000 | Large Shareholder | 3,087,216 | 2021-01-07 | Filing | |
| $10.50 | 76,228 | Director | 691,613 | 2020-02-28 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.45 | 447 | Officer | 277,499 | 2023-12-11 | Filing | |
| $1.53 | 2,543 | Officer | 277,946 | 2023-12-07 | Filing | |
| $1.53 | 2,248 | Officer | 280,489 | 2023-12-07 | Filing | |
| $1.53 | 188 | Officer | 282,737 | 2023-12-07 | Filing | |
| $1.45 | 331 | Officer | 193,547 | 2023-12-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,409,217 | $2,466,130 | 0% | |
| 2. | 434,856 | $760,998 | 0% | |
| 3. | 391,936 | $685,889 | 0% | |
| 4. | 300,274 | $525,605 | 0% | |
| 5. | 193,588 | $338,779 | 0.13% |
News See All
DermTech, Inc. (NASDAQ:DMTK) Q3 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to DermTech's Third Quarter 2023 Financial Results Call. At this time, all participants are in a listen-only mode.
DermTech, Inc. (NASDAQ:DMTK) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to DermTech’s Second Quarter 2023 Financial Results Call. At this time, all participants are in a listen-only mode.
DermTech, Inc. (NASDAQ:DMTK) Q1 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to DermTech’s First Quarter 2023 Financial Results Call. At this time, all participants are in a listen-only mode.
DermTech, Inc. (NASDAQ:DMTK) Q4 2022 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to DermTech's Fourth Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen only mode.
Hedge Funds Are Piling Into DermTech, Inc. (DMTK)
At Insider Monkey, we pore over the filings of nearly 873 top investment firms every quarter, a process we have now completed for the latest reporting period.
Were Hedge Funds Right About DermTech, Inc. (DMTK)?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Is DermTech (DMTK) A Good Stock To Buy Now?
While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, virus news and stimulus talks, many smart money investors are starting to get cautious...
Here is What Hedge Funds Think About DermTech, Inc. (DMTK)
In this article you are going to find out whether hedge funds think DermTech, Inc. (NASDAQ:DMTK) is a good investment right now.